Skip to content

Caroline Dujardin

Active
Private limited companyfounded 2022active for 3 yearsRue Bel Fays 32, 4052 Chaudfontaine, BelgiumKBO/BCE: BE 0793.674.685

From the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Caroline Dujardin has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €170,749 and a net result of €74,749. Equity has been growing by about 72% per year since 2023. Its solvency ranks better than 85% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 17-11-2022 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.340.964.643 4052 Chaudfontaine, since 17-11-2022
Financial year end
31 March
Peppol
Reachable since 05-12-2025

Board and ownership

Board

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 31-03-2025
Gross margin
€108,763
▲ 13.8%
Turnover
≈ €200,000
estimated
Profit
€74,749
▲ 17.2%
Equity
€170,749
▲ 77.9%
Total assets
€187,674
▲ 32.4%
2026 accounts not filed, 1 day past the deadline
Filed on 23-09-2025PDF
Score breakdownraises riskFigures for financial year 2025 (filed on 24-09-2025)lowers riskLiquidity: current ratio 11.81, cash €127,814Sector: Human health activities (NACE 86)Size: total assets €187,674Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 86% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+7
equity 91.0% of total assets
Liquidity 100+13
short-term debt 8.1% · cash 68.1%
Profitability 100=
return on assets 39.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025highest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €16,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 11.81 (2.84 in 2024), above the usual 1.5. Short-term debt is 8.1% and cash 68.1% of total assets. 9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 80% on profitability and 86% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 11.81, cash €127,814
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €187,674
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Figures for financial year 2025 (filed on 24-09-2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 23-09-2025, 38 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2026
not filed
2025
38 days early
2024
48 days early
2023
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 29 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Key points

  • Positive: Equity rose in 2025from €96,000 to €170,749 ▲ 77.9% View
  • Positive: Higher solvency than 85% of companies in human healthsector median 63.0% · 20,678 companies 91.0% View

Comparable companies

These companies have the same main activity as Caroline Dujardin: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €183,000 and €213,000, founded between 2022 and 2023.

CompanyTotal assetsGross margin
Caroline Dujardin Chaudfontaine€187,674€108,763
ZH MEDICAL Liège€184,263€101,228
ThDerm Liège€206,611€103,901
Docteur Emilie GODINAS Esneux€193,848€110,096
AL Van Massenhove Héron€212,665€110,003
Gynecare SRL Modave€183,427€98,106
LV ENDOCRINE Chaudfontaine€204,571€97,303
Full comparison

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Caroline Dujardin

What is the company number of Caroline Dujardin?
The company number of Caroline Dujardin is 0793.674.685. The VAT number is the same number with BE in front: BE 0793.674.685.
Where is Caroline Dujardin based?
The registered office is at Rue Bel Fays 32, 4052 Chaudfontaine.Company details
What does Caroline Dujardin do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Caroline Dujardin?
The legal form of Caroline Dujardin is Private limited company (BV).
When was Caroline Dujardin founded?
Caroline Dujardin was founded on 17-11-2022.
Is Caroline Dujardin still active?
Yes, Caroline Dujardin is an active enterprise in the KBO register.
What is the turnover of Caroline Dujardin?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €108,763 and 43 comparable companies (NACE 86220). It probably lies between €170,000 and €270,000.Financials
Is Caroline Dujardin profitable?
In financial year 2025, Caroline Dujardin made a profit of €74,749.
Where can I find the annual accounts of Caroline Dujardin?
Caroline Dujardin filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.